Daniel Patrick O'Day - 01 Sep 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Sep 2026, 16:12:46 UTC
Prior SEC filing
04 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day

Key filing fact

Daniel Patrick O'Day filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 02 Sep 2026.

Key facts

  • This page summarizes Daniel Patrick O'Day's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Sep 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 04 Aug 2026.
  • Current net transaction value: -$2,229,592.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001638643 Primary reporting owner

O'Day Daniel Patrick

Relationship
Chairman & CEO, Director
Address
333 LAKESIDE DRIVE, FOSTER CITY
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Signature date
02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Sale

Transaction value
$236,014
Shares
-1,600
Change %
-0.27%
Price
$147.51
Shares after
590,533
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F2
GILD transaction

Common Stock

Sale

Transaction value
$1,185,722
Shares
-7,992
Change %
-1.4%
Price
$148.36
Shares after
582,541
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F3
GILD transaction

Common Stock

Sale

Transaction value
$807,856
Shares
-5,408
Change %
-0.93%
Price
$149.38
Shares after
577,133
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.

Footnote F2

Sale prices for the transactions reported range from $146.94 to $147.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F3

Sale prices for the transactions reported range from $147.95 to $148.93. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F4

Sale prices for the transactions reported range from $148.96 to $149.94. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .